Antidepressants for bipolar depression: A systematic review of randomized, controlled trials

American Journal of Psychiatry

Volumn 161, Issue 9, 2004, Pages 1537-1547

  Gijsman, Harm J ^a   Geddes, John R ^b   Rendell, Jennifer M ^b   Nolen, Willem A ^b   Goodwin, Guy M ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; IDAZOXAN; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; OLANZAPINE; PAROXETINE; PLACEBO; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ANXIETY; BIPOLAR DEPRESSION; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; EMBASE; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; MANIA; MEDLINE; NEUROSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCINFO; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW;

ADULT; AGED; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; PLACEBOS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 4444339446     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.161.9.1537     Document Type: Review

References (53)

1. Hlastala SA, Frank E, Mallinger AG, Thase ME, Ritenour AM, Kupfer DJ: Bipolar depression: an underestimated treatment challenge. Depress Anxiety 1997; 5:73-83
2. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB: A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60:2611-269
3. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser JD, Solomon DA, Leon AC, Rice JA, Keller MB: The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59:530-537
4. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LI, McElroy SC, Rush AJ, Kupka R, Frye MA, Bickel M, Post RM (the Stanley Foundation Bipolar Treatment Outcome Network): Demographic and illness characteristics of the first 261 patients. J Affect Disord 2001; 67:45-59
5. Lopez P, Mosquera F, de Leon J, Gutierrez M, Ezcurra J, Ramirez F, Gonzalez-Pinto A: Suicide attempts in bipolar patients. J Clin Psychiatry 2001; 62:963-966
6. Geddes J, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM: Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361:653-661
7. Prien RF, Klett CJ, Caffey EM: Lithium carbonate and imipramine in prevention of affective episodes. Arch Gen Psychiatry 1973; 29:420-425
8. Lewis J, Winokur G: The induction of mania: a natural history study with controls. Arch Gen Psychiatry 1982; 39:303-306
9. Wehr TA, Goodwin FK: Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36:555-559
10. Maj M, Pirozzi R, Magliano L, Bartoli L: The prognostic significance of "switching" in patients with bipolar disorder: a 10-year prospective follow-up study. Am J Psychiatry 2002; 159: 1711-1717
11. Bhagwagar Z, Goodwin GM: The role of lithium in the treatment of bipolar depression. Clin Neurosci Res 2002; 2:222-227
12. Blanco C, Laje G, Olfson M, Marcus SC, Pincus HA: Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry 2002; 159:1005-1010
13. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC: A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA 1992; 268:240-248
14. Cipriani A, Geddes J: Comparison of systematic and narrative reviews: the example of the atypical antipsychotics. Epidemiol Psichiatr Soc 2003; 12:146-153
15. Mulrow CD, Oxman AD: Cochrane Collaboration Handbook, 4th ed. Oxford, UK, Update Software, 1997
16. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188
17. Cook RJ, Sackett DL: The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310:452-454
18. Aberg-Wistedt A: A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. Acta Psychiatr Scand 1982; 66:50-65
19. Kessell A, Holt NF: A controlled study of a tetracyclic antidepressant-maprotiline (Ludiomil). Med J Aust 1975; 1:773-776
20. Watanabe S, Yokoyama S, Kubo S, Iwai H, Kuyama C: A double-blind controlled study of clinical efficacy of maprotiline and amitriptyline in depression. Fol Psychiatr Neurol Jpn 1978; 32: 1-31
21. Fieve RR, Platman SR, Plutchik RR: The use of lithium in affective disorders, I: acute endogenous depression. Am J Psychiatry 1968; 125:487-491
22. Fabre LF, Brodie KH, Garver D, Zung WWK: A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients. J Clin Psychiatry 1983; 44:88-94
23. Merideth CH, Feighner JP: The use of bupropion in hospitalized depressed patients. J Clin Psychiatry 1983; 44:85-87
24. Amsterdam JD: Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. J Clin Psychopharmacol 1998; 18:414-417
25. Baumhackl U, Biziere K, Fischbach R, Geretsegger C, Hebenstreit G, Radmayr E, Stabl M: Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study. Br J Psychiatry Suppl 1989; 6:78-83
26. Benedetti F, Barbini B, Lucca A, Campori E, Colombo C, Smeraldi E: Sleep deprivation hastens the antidepressant action of fluoxetine. Eur Arch Psychiatry Clin Neurosci 1997; 247: 100-103
27. Ebert D, Jaspert A, Murata H, Kaschka WP: Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in non-resistant depressed patients. Psychopharmacology (Berl) 1995; 118:223-225
28. Vieta E, Martinez-Aran A, Goikolea JM, Torrent C, Colom F, Benabarre A, Reinares M: A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002; 63:508-512
29. Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A: Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60:1079-1088; correction, 2004; 61:176
30. Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD: Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001; 158:906-912
31. Cohn JB, Collins G, Ashbrook E, Wernicke JF: A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989; 4:313-322
32. Himmelhoch JM, Fuchs CZ, Symons BJ: A double-blind study of tranylcypromine treatment of major anergic depression. J Nerv Ment Dis 1982; 170:628-634
33. Mendlewicz J, Youdim MB: Antidepressant potentiation of 5-hydroxytryptophan by L-deprenyl in affective illness. J Affect Disord 1980; 2:137-146
34. Silverstone T: Moclobemide vs imipramine in bipolar depression: a multicentre double-blind clinical trial. Acta Psychiatr Scand 2001; 104:104-109
35. Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JF: A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994; 55: 391-393
36. Himmelhoch JM, Thase ME, Mallinger AG, Houck P: Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991; 148:910-916
37. De Wilde JE, Doogan DP: Fluvoxamine and chlorimipramine in endogenous depression. J Affect Disord 1982; 4:249-259
38. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I: Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157:124-126
39. Grossman F, Potter WZ, Brown EA, Maislin G: A double-blind study comparing idazoxan and bupropion in bipolar depressed patients. J Affect Disord 1999; 56:237-243
40. Bocchetta A, Bernardi F, Burrai C, Pedditzi M, Del Zompo M: A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives. Acta Psychiatr Scand 1993; 88:434-439
41. Leibenluft E: Issues in the treatment of women with bipolar illness. J Clin Psychiatry 1997; 58(suppl 15):5-11
42. Sachs GS: Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 1996; 16(2 suppl 1):32S-47S
43. Zornberg GL, Pope HG: Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993; 13:397-408
44. Compton MT, Nemeroff CB: The treatment of bipolar depression. J Clin Psychiatry 2000; 61(suppl 9):57-67
45. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP: The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med 2000(April Special Number)
46. Geddes J, Butler R, Hatcher S: Depressive disorders. Clin Evid 2003; 9:1034-1057
47. Peet M: Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164:549-550
48. Bottlender R, Rudolf D, Strauss A, Moller HJ: Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression. Eur Arch Psychiatr Clin Neurosci 1998; 248:296-300
49. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD: A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999; 60:79-88
50. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision). Am J Psychiatry 2002; 159(April suppl)
51. Goodwin GM: Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003; 17:149-173
52. Moller H-J, Grunze H: Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 2000; 250: 57-68
53. Post RM, Denicoff KD, Leverich GS, Frye MA: Drug-induced switching in bipolar disorder: epidemiology and therapeutic implications. CNS Drugs 1997; 8:352-365